2007 “Deals Made” as listed in eVestor

* denotes WAN investor-member

 

January

ConjuGon, $3.3 million by Rosetta Partners

BioSystems Development, $715,000 by Marshfield Investment Partners* and Silicon Pastures*

 

February

NimbleGen Systems, $12.5 million by undisclosed invcstors

PDM Solar, $75,000 by Central Wisconsin Business Angels* and others

C5-6 Technologies, $200,000 by MDC Venture-Debt Fund*

BioSystem Development, $200,000 by MDC Venture-Debt Fund*

 

March

GenTel BioSciences, $2 million by Wisconsin Investment Partners*, NEW Capital Fund* and others

North Prairie Productions, $25 million by various investors

 

April

Cellectar, $7 million by Continuum Investment Partners and other angel investors (deal closed 10/06)

 

May

Mithridion, Inc., $1.2 million by Venture Investors, WARF, and Rosetta Partners

Bomboard LLC, $780,000 by family and friends

 

June

TrafficCast International, $2 million by Phenomenelle Angels*, NEW Capital Fund*, Women Angels* and individual angels

ProCertus BioPharm, $2.3 million by Venture Investors* and Novartis Venture Fund

 

(NimbleGen Systems’ much anticipated IPO was scraped in lieu of $272.5 million in cash from acquirer Roche)

 

July

None listed

 

August

CDI Bioscience Inc. (formerly Clonex Development), $3 million by Battelle Ventures

Lake Resources Group Inc, $375,000 by individuals

Nemean Networks LLC, $1.5 million by Badger Alumni Capital Network

PercipEnz Technologies, $1 million by NEW Capital Fund*, Wisconsin Investment Partners*, and Silicon Pastures*

 

September

Virent Energy Systems, Inc., $21 million by Stark Investments, Venture Investors LLC* and Cargill Ventures

OpGen, $23.6 million by CHL Medical Partners, Highland Capital Partners, Versant Ventures and Mason Wells*

Novo Group, $1.025 million by individual investors

 

October-November

eVestor not published

 

December

Stemina Biomarker Discovery, $1.5 million by DaneVest*, Phenomenelle Angels* and others

Ven-T Boats Inc., $2 million by Successful Entrepreneurs Fund*

Deltanoid Pharmaceuticals, $12 million by WARF, Mason Wells*, Venture Investors* and individual angels